No abstract

No abstract

Four Pb(ii) complexes of (iso)nicotinohydrazide-based ligands and different anionic coligands (azide, nitrate, acetate and iodide) have been synthesized and characterized by structural, analytical and spectroscopic methods. The mono-deprotonated or neutral forms of the ligands coordinate in a tridentate fashion via two nitrogen and one oxygen donor atoms to the Pb. Single-crystal X-ray crystallography showed that the molecular complexes can aggregate into larger entities depending upon the anion coordinated to the metal centre. In all four complexes the lead center is hemidirectionally coordinated and, consequently, it is sterically ideal for establishing tetrel bonding interactions. In the crystal structures of all complexes, the lead atoms participate in short contacts with nitrogen atoms. These contacts are shorter than the sums of the van der Waals radii and larger than the sums of the covalent radii. The tetrel bonding interactions interconnect the covalently bonded units (monomers or dimers) into supramolecular assemblies (chains and 3D structures). We have analysed the interesting supramolecular assemblies observed in the solid state of all four complexes by means of DFT calculations.

Nano-sized particles of manganese oxides have been prepared by a very simple and cheap process using a decomposing aqueous solution of manganese nitrate at 100 °C. Scanning electron microscopy, transmission electron microscopy and X-ray diffraction spectrometry have been used to characterize the phase and the morphology of the manganese oxide. The nano-sized manganese oxide shows efficient catalytic activity toward water oxidation and the epoxidation of olefins in the presence of cerium(IV) ammonium nitrate and hydrogen peroxide, respectively.

Based on their mechanisms-of-action, CD20 monoclonal antibodies (mAbs) are grouped into Type I [complement-dependent cytotoxicity (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC)] and Type II [programmed cell death (PCD) and ADCC] mAbs. We generated 17 new hybridomas producing CD20 mAbs of different isotypes and determined unique heavy and light chain sequence pairs for 13 of them. We studied their epitope binding, binding kinetics and structural properties and investigated their predictive value for effector functions, i.e. PCD, CDC and ADCC. Peptide mapping and CD20 mutant screens revealed that 10 out of these 11 new mAbs have an overlapping epitope with the prototypic Type I mAb rituximab, albeit that distinct amino acids of the CD20 molecule contributed differently. Binding kinetics did not correlate with the striking differences in CDC activity among the mIgG2c mAbs. Interestingly, chimerization of mAb m1 resulted in a mAb displaying both Type I and II characteristics. PCD induction was lost upon introduction of a mutation in the framework of the heavy chain affecting the elbow angle, supporting that structural changes within this region can affect functional activities of CD20 mAbs. Together, these new CD20 mAbs provide further insights in the properties dictating the functional efficacy of CD20 mAbs.